Production of recombinant peanut allergen Ara h 2 using Lactococcus lactis

Research output: Contribution to journalJournal articleResearchpeer-review

Documents

Jacob Glenting, Lars K. Poulsen, Kentaro Kato, Søren Madsen, Hanne Frøkiær, Camilla Wendt, Helle W Sørensen

Natural allergen sources can supply large quantities of authentic allergen mixtures for use as immunotherapeutics. However, such extracts are complex, difficult to define, vary from batch to batch, which may lead to unpredictable efficacy and/or unacceptable levels of side effects. The use of recombinant expression systems for allergen production can alleviate some of these issues. Several allergens have been tested in high-level expression systems and in most cases show immunereactivity comparable to their natural counterparts. The gram positive lactic acid bacterium Lactococcus lactis is an attractive microorganism for use in the production of protein therapeutics. L. lactis is considered food grade, free of endotoxins, and is able to secrete the heterologous product together with few other native proteins. Hypersensitivity to peanut represents a serious allergic problem. Some of the major allergens in peanut have been described. However, for therapeutic usage more information about the individual allergenic components is needed. In this paper we report recombinant production of the Ara h 2 peanut allergen using L. lactis.
Original languageEnglish
Article number28
JournalMicrobial Cell Factories
Volume6
Number of pages10
ISSN1475-2859
DOIs
Publication statusPublished - 2007

Number of downloads are based on statistics from Google Scholar and www.ku.dk


No data available

ID: 43535155